AqueSys Garners $35,000,000 Series C Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    9834 Research Dr. Irvine, CA 92618
  • Company Description
    The company is developing a device treatment for primary open angle glaucoma.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    The Series C raise is designed to build upon the promising clinical results our proprietary technology has generated in multiple patient populations.
  • M&A Terms
  • Venture Investor
    Longitude Capital Management
  • Venture Investor
    Rho Ventures
  • Venture Investor
    Accuitive Medical Ventures (AMV)
  • Venture Investor
    The Carlyle Group
  • Venture Investor
    SV Life Sciences